These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Theory of pathogenesis in primary hyperuricamia]. Mertz DP. Med Klin; 1975 Jul 11; 70(28-29):1187-98. PubMed ID: 170496 [No Abstract] [Full Text] [Related]
8. [Enzymopathies as a cause of hyperuricemia]. Eyman E, Kawenoki-Minc E. Reumatologia; 1977 Jul 11; 15(3):375-81. PubMed ID: 929012 [No Abstract] [Full Text] [Related]
9. Allopurinol and thiopurinol: effect in vivo on urinary oxypurine excretion and rate of synthesis of their ribonucleotides in different enzymatic deficiencies. Auscher C, Mercier N, Pasquier C, Delbarre F. Adv Exp Med Biol; 1974 Jul 11; 41():657-62. PubMed ID: 4832592 [No Abstract] [Full Text] [Related]
10. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)]. Delbarre F, Auscher C, de Gery A, Brouilhet H, Olivier JL. Presse Med (1893); 1968 Dec 14; 76(49):2329. PubMed ID: 5737251 [No Abstract] [Full Text] [Related]
11. Seminars on Lesch-Nyhan syndrome. Aspects of purine metabolism. Balis ME. Fed Proc; 1968 Dec 14; 27(4):1067-74. PubMed ID: 4968794 [No Abstract] [Full Text] [Related]
12. Origin and extrarenal elimination of uric acid in man. Sorensen LB, Levinson DJ. Nephron; 1975 Dec 14; 14(1):7-20. PubMed ID: 1124137 [Abstract] [Full Text] [Related]
13. Alteration of purine control mechanisms in patients with the Lesch-Nyhan mutation. Benke PJ. Wis Med J; 1971 Jul 14; 70(7):174-5. PubMed ID: 5560233 [No Abstract] [Full Text] [Related]
14. Disorders associated with purine and pyrimidine metabolism. Edwards NL, Fox IH. Spec Top Endocrinol Metab; 1984 Jul 14; 6():95-140. PubMed ID: 6098039 [Abstract] [Full Text] [Related]
15. [Familial xanthinuria, 2 new cases]. Pereg Macazaga V, García Fernández H, Regúlez M, Elorza Olabegoya JR, Beitia Martín JJ, Vázquez García JA. Med Clin (Barc); 1984 Mar 03; 82(8):364-5. PubMed ID: 6546962 [No Abstract] [Full Text] [Related]
16. Genetic aspects of gout. Becker MA, Seegmiller JE. Annu Rev Med; 1974 Mar 03; 25(0):15-28. PubMed ID: 4604505 [No Abstract] [Full Text] [Related]
17. Purine metabolism in Lesch-Nyhan syndrome versus Kelley-Seegmiller syndrome. Mateos EA, Puig JG. J Inherit Metab Dis; 1994 Mar 03; 17(1):138-42. PubMed ID: 8051925 [No Abstract] [Full Text] [Related]
18. Metabolic implications of the Lesch-Nyhan syndrome. Emmerson BT. Aust N Z J Med; 1972 Feb 03; 2(1):88-90. PubMed ID: 4502722 [No Abstract] [Full Text] [Related]
19. [Mechanism of action and role of xanthine oxidoreductases (author's transl)]. Jezewska MM. Postepy Biochem; 1974 Feb 03; 20(3):259-79. PubMed ID: 4849147 [No Abstract] [Full Text] [Related]
20. Regulation of purine biosynthesis and turnover. Wyngaarden JB. Adv Enzyme Regul; 1976 Feb 03; 14():25-42. PubMed ID: 184697 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]